Drugs / Aolanti Weipang Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03971383 | Jun 2019 → Oct 2020 | dyspepsia | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aolanti Weipang Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03971383 ↗ |
| Route | Oral | “given orally” NCT03971383 ↗ |